Alcon Pharms Ltd Drug Patent Portfolio

Alcon Pharms Ltd owns 3 orange book drugs protected by 8 US patents Given below is the list of Alcon Pharms Ltd's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7084130 Intraocular irrigating solution having improved flow characteristics 29 Nov, 2021 Expired
US5631287 Storage-stable prostaglandin compositions 22 Dec, 2014 Expired
US5849792 Storage-stable prostaglandin compositions 22 Dec, 2014 Expired
US6011062 Storage-stable prostaglandin compositions 22 Dec, 2014 Expired
US5889052 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension 02 Dec, 2014 Expired
US5540918 Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions 30 Jan, 2014 Expired
US5510383 Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension 03 Aug, 2013 Expired
US5540918 Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions 30 Jul, 2013 Expired


Given below is the list of recent legal activities going on the following drug patents of Alcon Pharms Ltd.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 18 Jan, 2018 US7084130
Recordation of Patent Grant Mailed 01 Aug, 2006 US7084130
Patent Issue Date Used in PTA Calculation 01 Aug, 2006 US7084130
Issue Notification Mailed 12 Jul, 2006 US7084130
Receipt into Pubs 19 Jun, 2006 US7084130
Dispatch to FDC 12 Jun, 2006 US7084130
Application Is Considered Ready for Issue 12 Jun, 2006 US7084130
Receipt into Pubs 24 May, 2006 US7084130
Mail Miscellaneous Communication to Applicant 27 Mar, 2006 US7084130
Miscellaneous Communication to Applicant - No Action Count 24 Mar, 2006 US7084130
Pubs Case Remand to TC 06 Jan, 2006 US7084130
Issue Fee Payment Verified 18 Feb, 2005 US7084130
Issue Fee Payment Received 18 Feb, 2005 US7084130
Receipt into Pubs 23 Dec, 2004 US7084130
Workflow - File Sent to Contractor 22 Dec, 2004 US7084130


Alcon Pharms Ltd's Family Patents


Family Patents



Alcon Pharms Ltd Drug List

Given below is the complete list of Alcon Pharms Ltd's drugs and the patents protecting them.


1. Betaxon

Betaxon is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5540918
(Pediatric)
Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions 30 Jan, 2014
(10 years ago)
Expired
US5540918 Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions 30 Jul, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Betaxon's drug page


2. Navstel

Navstel is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7084130 Intraocular irrigating solution having improved flow characteristics 29 Nov, 2021
(2 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Navstel's drug page


3. Travatan

Travatan is protected by 5 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5631287 Storage-stable prostaglandin compositions 22 Dec, 2014
(9 years ago)
Expired
US5849792 Storage-stable prostaglandin compositions 22 Dec, 2014
(9 years ago)
Expired
US6011062 Storage-stable prostaglandin compositions 22 Dec, 2014
(9 years ago)
Expired
US5889052 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension 02 Dec, 2014
(9 years ago)
Expired
US5510383 Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension 03 Aug, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Travatan's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List